{
    "2019-11-11": [
        [
            {
                "time": "",
                "original_text": "贝达药业控股股东方面拟减持不超4.17%股份 拟减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "控股股东",
                        "减持",
                        "4.17%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：提名汪炜为董事候选人不会对公司规范运作及公司治理产生不利影响",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "提名",
                        "董事候选人",
                        "汪炜",
                        "公司治理"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：3名股东拟合计减持不超4.17%股份 拟减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股东",
                        "减持",
                        "4.17%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：控股股东拟合计减持计不超过公司4.17%股份 减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "控股股东",
                        "减持",
                        "4.17%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}